Moneycontrol PRO

business

Some stocks overpriced, but can go with flow: Malkani

Despite the recent run up in pharma stocks, this week, problems related to the US FDA have made a come back. Jagdish Malkani, member at BSE and NSE believes though the Indian pharmaceuticals industry is a great play, investors should not get carried away with it.

first published: Sep 12, 2014 04:00 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347